-
scattering with computer modelling such as molecular dynamics simulations and AI-assisted data mining. The new technical capabilities will help bridge the current gap in biocide development, i.e., to link
-
have or expect to obtain a first or upper second-class degree in a relevant subject from a UK university, or equivalent standard abroad. Prior research experience, for instance in molecular biology
-
in genotyping, molecular biology and Drosophila work. CDN has close partnership with the Medical Research Council (MRC) and CDN researchers, together with clinical researchers from King’s, make up
-
, to industrial catalysis and green energy production. This PhD project offers a rare opportunity to explore hydrogen surface collisions at a fundamental, molecular level to gain unprecedented insight into the role
-
& Neuroscience and is located at Guy’s campus. Researchers have access to support facilities in genotyping, molecular biology and Drosophila work. CDN has close partnership with the Medical Research Council (MRC
-
nanomanufacturing process to overcome the challenges of atomic sale precision, feature size and defects rates for quantum dots. In this project, molecular dynamics simulation study of light matter interaction
-
pigmented and non-pigmented silicone elastomers developed within AMFaces. The successful candidate will simulate aging through cellular senescence and ECM modifications, incorporate immune cells to reflect
-
supportive and friendly team, you will learn how to design and perform experiments that interrogate the molecular and cellular mechanisms regulated by ADAM15 and ADAM12 in glioma, employing cellular
-
(ToF-PET) provides critical functional and molecular insights to improve cancer staging but is currently limited by detector timing resolution and sensitivity. Metascintillators, an emerging family of
-
? This MRC-funded PhD project will use an integrative multi-omics framework to explore the molecular landscape of cystic kidney disease to reveal unknown disease mechanisms and identify new therapeutic avenues